Stock Market News4 days Amgen’s Lumakras Gets FDA Nod for Expanded Use in Colorectal Cancer Zacks
The FDA approves Amgen’s Lumakras in combination with Vectibix for treating previously treated adults with KRAS G12C-mutated metastatic colorectal cancer.
XThe FDA approves Amgen’s Lumakras in combination with Vectibix for treating previously treated adults with KRAS G12C-mutated metastatic colorectal cancer.
X